252 related articles for article (PubMed ID: 9160787)
41. [Renal kallikrein-kinin system and control of blood pressure (author's transl)].
Distler A; Wolff HP
Klin Wochenschr; 1979 Oct; 57(19):1037-45. PubMed ID: 392177
[TBL] [Abstract][Full Text] [Related]
42. Salt-sensitive hypertension in bradykinin B2 receptor knockout mice.
Alfie ME; Yang XP; Hess F; Carretero OA
Biochem Biophys Res Commun; 1996 Jul; 224(3):625-30. PubMed ID: 8713099
[TBL] [Abstract][Full Text] [Related]
43. Antihypertensive effects of cicletanine and renal protection in Dahl salt-sensitive rats.
Uehara Y; Numabe A; Hirawa N; Kawabata Y; Iwai J; Ono H; Matsuoka H; Takabatake Y; Yagi S; Sugimoto T
J Hypertens; 1991 Aug; 9(8):719-28. PubMed ID: 1655882
[TBL] [Abstract][Full Text] [Related]
44. Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats.
O'Donnell MP; Kasiske BL; Katz SA; Schmitz PG; Keane WF
Hypertension; 1992 Nov; 20(5):651-8. PubMed ID: 1428116
[TBL] [Abstract][Full Text] [Related]
45. [Kidney kallikrein-kinin system in different mechanisms of diuresis].
Zharova EA; Sokolova RI; Nekrasova AA
Biull Eksp Biol Med; 1977 Aug; 84(8):141-3. PubMed ID: 907812
[TBL] [Abstract][Full Text] [Related]
46. Urinary kallikrein in rats bred for susceptibility and resistance to the hypertensive effect of salt and in New Zealand genetically hypertensive rats.
Carretero OA; Scicli AG; Piwonska A; Koch J
Mayo Clin Proc; 1977 Jul; 52(7):465-7. PubMed ID: 875472
[TBL] [Abstract][Full Text] [Related]
47. Hypertension in Dahl salt-sensitive rats: biochemical and immunohistochemical studies.
Bouhnik J; Richoux JP; Huang H; Savoie F; Baussant T; Alhenc-Gelas F; Corvol P
Clin Sci (Lond); 1992 Jul; 83(1):13-22. PubMed ID: 1325316
[TBL] [Abstract][Full Text] [Related]
48. Hachimi-jio-gan extract protects the kidney from hypertensive injury in Dahl salt-sensitive rat.
Hirawa N; Uehara Y; Kawabata Y; Numabe A; Takada S; Nagoshi H; Gomi T; Ikeda T; Omata M
Am J Chin Med; 1996; 24(3-4):241-54. PubMed ID: 8982436
[TBL] [Abstract][Full Text] [Related]
49. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery.
Bledsoe G; Shen B; Yao Y; Zhang JJ; Chao L; Chao J
Hum Gene Ther; 2006 May; 17(5):545-55. PubMed ID: 16716111
[TBL] [Abstract][Full Text] [Related]
50. Restoration of endothelial cell function by chronic cicletanine treatment in Dahl salt-sensitive rats with salt-induced hypertension.
Hirawa N; Uehara Y; Kawabata Y; Akie Y; Ichikawa A; Funahashi N; Goto A; Omata M
Hypertens Res; 1996 Dec; 19(4):263-70. PubMed ID: 8986457
[TBL] [Abstract][Full Text] [Related]
51. Renal function and sodium balance in conscious Dahl S and R rats.
Roman RJ; Osborn JL
Am J Physiol; 1987 May; 252(5 Pt 2):R833-41. PubMed ID: 3578550
[TBL] [Abstract][Full Text] [Related]
52. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
Wolf WC; Yoshida H; Agata J; Chao L; Chao J
Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
[TBL] [Abstract][Full Text] [Related]
53. Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats.
Roman RJ; Alonso-Galicia M; Wilson TW
Am J Hypertens; 1997 May; 10(5 Pt 2):63S-67S. PubMed ID: 9160783
[TBL] [Abstract][Full Text] [Related]
54. Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases.
Chao J; Chao L
Pharmacol Res; 1997 Jun; 35(6):517-22. PubMed ID: 9356201
[TBL] [Abstract][Full Text] [Related]
55. Interferon gamma attenuates hypertensive renal injury in salt-sensitive Dahl rats.
Ishimitsu T; Uehara Y; Numabe A; Tsukada H; Ogawa Y; Iwai J; Ikeda T; Matsuoka H; Sugimoto T; Yagi S
Hypertension; 1992 Jun; 19(6 Pt 2):804-8. PubMed ID: 1592485
[TBL] [Abstract][Full Text] [Related]
56. Isoelectric focusing patterns of urinary kallikrein in Dahl salt-hypertension susceptible and resistant rats.
Rapp JP; McPartland RP; Batten CL
Hypertension; 1984; 6(4):519-25. PubMed ID: 6378789
[TBL] [Abstract][Full Text] [Related]
57. Renal cyclic 3',5'-guanosine monophosphate and sodium excretion in Dahl salt-resistant and Dahl salt-sensitive rats: comparison of the roles of bradykinin and nitric oxide.
Millatt LJ; Siragy HM
J Hypertens; 2000 Oct; 18(10):1491-6. PubMed ID: 11057438
[TBL] [Abstract][Full Text] [Related]
58. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats.
Chen PY; Sanders PW
J Clin Invest; 1991 Nov; 88(5):1559-67. PubMed ID: 1658045
[TBL] [Abstract][Full Text] [Related]
59. The renal kallikrein-kinin system in human and in experimental hypertension.
Carretero OA; Scicli AG
Klin Wochenschr; 1978; 56 Suppl 1():113-25. PubMed ID: 366276
[TBL] [Abstract][Full Text] [Related]
60. Renal kallikrein-kinin, prostaglandin E2, and dopamine systems in young normotensive subjects with a family history of essential hypertension.
Shimamoto K; Ura N; Nishimura M; Iimura O
Am J Med Sci; 1994 Feb; 307 Suppl 1():S70-4. PubMed ID: 8141169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
